Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

14.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
14.8K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.4K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.6K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Workplace Wellness: A Comprehensive Approach to Sleep Apnea Screening in Onsite Health.

Workplace health & safety·2024
Same author

Implementation of a Prediabetes Risk Test for an Underserved Population in a Federally Qualified Health Center.

Clinical diabetes : a publication of the American Diabetes Association·2023
Same author

Comparing satisfaction and outcomes in on-campus versus virtual education for nurse practitioner students.

Journal of the American Association of Nurse Practitioners·2023
Same author

Blood Pressure Control and the Association With Diabetes Mellitus Incidence: Results From SPRINT Randomized Trial.

Hypertension (Dallas, Tex. : 1979)·2019
Same author

Developing Innovative On-Campus Intensives to Enhance Distance-Based Nurse Practitioner Programs.

The Journal of nursing education·2019
Same author

Hyperglycemia Syndromes.

The Nursing clinics of North America·2018

Related Experiment Video

Updated: Mar 15, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.6K

Type 1 diabetes & cardiovascular disease.

Kathryn Evans Kreider1, Blanca I Padilla

  • 1Kathryn Evans Kreider is an assistant professor at Duke University School of Nursing, Durham, N.C., and currently practices as an NP in Endocrinology at Duke University Medical Center. Blanca I. Padilla is an assistant professor at Duke University School of Nursing, Durham, N.C., and currently practices as an NP in Endocrinology at Duke University Medical Center.

The Nurse Practitioner
|September 14, 2016
PubMed
Summary

Individuals with type 1 diabetes mellitus (T1DM) face high cardiovascular disease (CVD) risk. Lifestyle changes and medication can help manage this risk, reducing the likelihood of CVD in T1DM patients.

More Related Videos

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.4K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.7K

Related Experiment Videos

Last Updated: Mar 15, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.6K
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.4K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.7K

Area of Science:

  • Cardiology
  • Endocrinology
  • Diabetes Management

Background:

  • Type 1 diabetes mellitus (T1DM) significantly increases the risk of cardiovascular disease (CVD).
  • Cardiovascular risk factors in T1DM can be mitigated through targeted interventions.
  • Healthcare providers, specifically nurse practitioners (NPs), require updated knowledge on evidence-based CVD management for T1DM.

Purpose of the Study:

  • To outline evidence-based management strategies for reducing cardiovascular disease risk in patients with type 1 diabetes mellitus.
  • To emphasize the role of nurse practitioners in educating and counseling T1DM patients on self-management interventions.
  • To provide guidance on lifestyle modifications and medication adherence for CVD prevention in T1DM.

Main Methods:

  • Review of current clinical guidelines and research on T1DM and CVD.
  • Analysis of risk factors amenable to lifestyle modification and pharmacotherapy.
  • Focus on educational strategies for nurse practitioners to facilitate patient self-management.

Main Results:

  • Lifestyle modifications (diet, exercise, smoking cessation) are crucial for CVD risk reduction in T1DM.
  • Pharmacological interventions can effectively manage hypertension, dyslipidemia, and other CVD risk factors.
  • Patient education and adherence support are key components of successful self-management.

Conclusions:

  • Comprehensive management integrating lifestyle and medication is essential for mitigating CVD risk in T1DM.
  • Nurse practitioners play a vital role in empowering T1DM patients with self-management skills to prevent CVD.
  • Proactive and evidence-based approaches are necessary to improve long-term cardiovascular outcomes for individuals with T1DM.